Health Catalyst, Inc.

For the period ended Mar 31, 2026. Filed May 11, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 11, 2026

HCAT$1.44-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets as of (unaudited) and

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

	As ofMarch 31,	As ofDecember 31,
	2026	2025
(unaudited)
Assets
Current assets:
Cash and cash equivalents	$59,864	$50,814
Short-term investments	48,959	44,918
Accounts receivable, net(1)	59,146	59,128
Prepaid expenses and other assets	14,343	14,447
Total current assets	182,312	169,307
Property and equipment, net	34,935	33,838
Intangible assets, net	69,332	77,678
Operating lease right-of-use assets	6,255	6,640
Goodwill	113,251	209,073
Other assets	6,117	6,107
Total assets	$412,202	$502,643
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$11,694	$9,363
Accrued liabilities	20,825	18,697
Deferred revenue(1)	69,736	56,107
Operating lease liabilities	3,731	3,779
Current portion of long-term debt	1,627	1,627
Total current liabilities	107,613	89,573
Long-term debt, net of current portion	151,738	151,624
Deferred revenue, net of current portion	227	410
Operating lease liabilities, net of current portion	13,482	14,208
Contingent consideration liabilities, net of current portion	156	250
Other liabilities	841	798
Total liabilities	274,057	256,863
Commitments and contingencies (Note 15)

Stockholders’ equity:
Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding as of March 31, 2026 and December 31, 2025	—	—
Common stock, $0.001 par value per share, and additional paid-in capital; 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 73,748,666 and 72,027,332 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	1,612,808	1,608,840
Accumulated deficit	(1,475,672)	(1,364,646)
Accumulated other comprehensive income	1,009	1,586
Total stockholders’ equity	138,145	245,780
Total liabilities and stockholders’ equity	$412,202	$502,643

(1)Includes amounts attributable to related party transactions. See Note 17 for further details.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.